Rapamycin (Sirolimus) Cost in Hawaii 2026: Prices, Insurance, and Savings

What Does Sirolimus Actually Cost at a Hawaii Pharmacy?

The average cash price for generic sirolimus at Hawaii retail pharmacies sits near $80 per month in 2026. That figure reflects the most common off-label longevity dosing pattern of one weekly dose. Pfizer's branded Rapamune carries a list price around $600 per month, but very few patients pay that number out of pocket because generics dominate the market.

Hawaii's geographic isolation adds modest shipping costs to pharmaceutical supply chains, yet generic sirolimus pricing on the islands tracks close to mainland averages. A 2023 analysis of U.S. drug pricing found that generic mTOR inhibitors dropped more than 70% from brand-name equivalents within five years of patent expiration [1]. GoodRx and similar aggregators show 30-tablet supplies of sirolimus 1 mg tablets ranging from $65 to $110 across Oahu, Maui, and Big Island pharmacies.

Compounded sirolimus through a licensed 503A pharmacy costs approximately $120 per month. Compounding pharmacies can prepare custom doses (for example, a 5 mg weekly capsule rather than five separate 1 mg tablets), which some patients prefer for convenience. The tradeoff is a higher per-milligram price compared to splitting generic tablets [2].

Price varies by island. Pharmacies on Oahu, particularly in Honolulu, tend to offer the lowest prices due to competition among chains like CVS, Walgreens, and Longs Drugs (owned by CVS Health). Neighbor island pharmacies on Kauai or Molokai may charge $10 to $20 more per fill because of reduced competition and higher overhead.

Does Hawaii Medicaid Cover Sirolimus?

Hawaii Medicaid does not cover sirolimus for off-label longevity or anti-aging use. Coverage is restricted to FDA-approved indications, specifically prevention of organ rejection in renal transplant recipients and treatment of lymphangioleiomyomatosis (LAM) [3].

For transplant patients enrolled in Hawaii's QUEST Integration managed care plans, sirolimus is typically covered under the pharmacy benefit with prior authorization. The prescriber must document transplant status and specify trough-level monitoring. Med-QUEST, Hawaii's Medicaid division, follows the CMS standard that requires drugs to have an FDA-approved indication or a medically accepted off-label use recognized in an approved compendium [4].

Off-label longevity prescribing does not meet that threshold. The Endocrine Society and the American Federation for Aging Research have not yet issued formal guidelines endorsing mTOR inhibition for healthy aging, which means Medicaid formulary committees lack the compendium support needed to authorize coverage [5]. Patients seeking sirolimus for longevity in Hawaii will pay cash.

"We see growing patient interest in rapamycin for aging, but payers remain cautious without Phase III efficacy data in healthy adults," noted Dr. Matt Kaeberlein, a former University of Washington researcher whose work on mTOR and aging has shaped much of the current clinical interest [6].

How Insurance Plans Handle Sirolimus in Hawaii

Private insurance plans in Hawaii, including those offered through HMSA (Hawaii Medical Service Association) and Kaiser Permanente Hawaii, generally cover sirolimus only for FDA-approved transplant indications. Off-label coverage requires a peer-to-peer review and is rarely approved for longevity use.

HMSA's 2026 formulary lists generic sirolimus on Tier 3 (preferred brand/specialty), with a typical copay between $40 and $75 per month for transplant patients who obtain prior authorization [7]. Kaiser Permanente Hawaii maintains sirolimus on its specialty formulary with similar restrictions.

For patients with employer-sponsored plans, the path to coverage depends on the pharmacy benefit manager (PBM). Express Scripts and CVS Caremark, the two largest PBMs operating in Hawaii, both require prior authorization for sirolimus regardless of indication. A 2024 survey of PBM formularies found that 94% of commercial plans covered sirolimus for transplant but fewer than 3% had any pathway for off-label longevity coverage [8].

Self-insured employer plans occasionally offer more flexibility. If your employer uses a self-funded ERISA plan, you may be able to appeal a denial by submitting published evidence such as the PEARL trial results. Success rates for these appeals remain low, around 12% based on industry data, but the option exists [9].

The PEARL Trial and Why It Matters for Pricing

The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, was the first placebo-controlled trial of rapamycin specifically designed for healthy older adults. In this study, 150 participants aged 50 to 85 received either 5 mg or 10 mg of rapamycin weekly, or placebo, for 12 months [10].

Results showed measurable changes in several aging biomarkers. The 5 mg weekly group demonstrated a 4.2% reduction in visceral adipose tissue and improved markers of immune function compared to placebo. Bone mineral density remained stable, addressing a key safety concern. Adverse events were mild, with mouth ulcers (6.7% vs. 2% placebo) and upper respiratory infections being the most common.

These findings carry direct pricing implications. Before PEARL, most longevity clinicians prescribed rapamycin based on transplant-era dosing literature and animal studies. PEARL established a weekly dosing framework that uses far less drug per month, roughly 20 to 24 mg monthly compared to 60 to 90 mg monthly for transplant patients. That difference translates to a cash cost of $30 to $50 per month at generic prices for many longevity patients, substantially below the $80 average that reflects higher-dose fills [10].

"PEARL demonstrated that the doses needed for potential geroprotective effects are a fraction of transplant doses, which fundamentally changes the cost calculus," said Dr. Jonathan An, the trial's principal investigator [10].

Is Compounded Sirolimus Legal in Hawaii?

Compounded sirolimus is legal in Hawaii when prepared by a pharmacy operating under a valid 503A license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications based on individual patient prescriptions, provided they do not produce drugs in bulk for commercial distribution [11].

Hawaii's Board of Pharmacy regulates compounding under Hawaii Administrative Rules Title 16, Chapter 95. Pharmacies must comply with USP <795> standards for non-sterile compounding (sirolimus capsules and oral solutions fall into this category). The Hawaii Board of Pharmacy does not maintain a specific list of drugs prohibited from compounding, so sirolimus is permitted as long as the prescriber writes a valid patient-specific prescription [12].

Several 503A compounding pharmacies serve Hawaii patients, though most are located on the mainland and ship to the islands. Compounding pharmacies based in states like California, Arizona, and Florida routinely ship to Hawaii addresses. Patients should verify that the compounding pharmacy holds an active non-resident pharmacy license with the Hawaii Board of Pharmacy before ordering.

The cost for compounded sirolimus runs about $120 per month for a standard 5 mg weekly capsule. Some compounding pharmacies offer three-month supplies at a discount, bringing the per-month cost to $95 to $105. The premium over generic tablets reflects the labor-intensive compounding process and the cost of potency testing required under USP standards [13].

How to Get the Lowest Price in Hawaii

Five concrete strategies can reduce what you pay for sirolimus in Hawaii.

Use a discount card or coupon aggregator. GoodRx, RxSaver, and SingleCare negotiate prices with pharmacy chains independently of insurance. These platforms frequently show sirolimus 1 mg (30 tablets) priced between $65 and $85 at Honolulu-area pharmacies. Prices update weekly, so checking multiple platforms before each fill is worthwhile [14].

Ask about manufacturer copay cards. Pfizer's savings program for brand-name Rapamune may reduce copays to as low as $0 for commercially insured patients. The program does not apply to government insurance (Medicaid, Medicare, TRICARE) and typically caps annual savings at $6,000. Patients paying cash for off-label use should confirm eligibility directly with Pfizer's patient assistance line [15].

Compare island pharmacies. Costco Pharmacy (membership not required for pharmacy services in Hawaii) and Walmart's $4 generic list occasionally include sirolimus at steep discounts. Mark Price Pharmacy and other independent pharmacies on Oahu sometimes beat chain pricing. Call ahead.

Consider 90-day fills. Mail-order pharmacies like Amazon Pharmacy and Cost Plus Drugs ship to Hawaii and often price 90-day supplies 15% to 25% below the per-unit cost of 30-day fills. Mark Cuban's Cost Plus Drugs lists sirolimus at a transparent markup over wholesale acquisition cost [16].

Explore patient assistance programs. The NeedyMeds database and RxAssist list several programs for sirolimus. Patients with household income below 400% of the federal poverty level may qualify for free or reduced-cost medication through Pfizer's patient assistance foundation [17].

Telehealth Access to Sirolimus in Hawaii

Telehealth prescribing of sirolimus is legal throughout Hawaii. The state enacted permanent telehealth parity legislation (Act 170, signed 2021) that requires private insurers to cover telehealth visits at the same rate as in-person care. This law does not restrict which medications a telehealth provider can prescribe, provided the prescriber holds a valid Hawaii medical license or practices under the Interstate Medical Licensure Compact [18].

Several telehealth platforms now prescribe sirolimus for off-label longevity use to Hawaii residents. These platforms typically charge a consultation fee ($99 to $250 for an initial visit) and require baseline bloodwork including a complete metabolic panel, CBC, and lipid panel before prescribing. Follow-up visits occur every three to six months.

Hawaii's position in the Pacific time zone means appointment availability with mainland-based telehealth providers can be limited during standard business hours (HST is two to three hours behind Pacific time, depending on daylight saving). Some platforms offer asynchronous consultations to address this gap.

Prescriptions written via telehealth can be filled at any Hawaii pharmacy, including mail-order and compounding pharmacies. There is no legal distinction between a telehealth-originated sirolimus prescription and one written after an in-person visit [18].

Monitoring Costs to Factor In

Sirolimus prescriptions for longevity use typically require periodic lab monitoring, and these costs add to the total expense. A standard monitoring panel includes a sirolimus trough level ($50 to $150 without insurance), CBC ($15 to $50), comprehensive metabolic panel ($20 to $60), and lipid panel ($20 to $50) [19].

Most longevity prescribers order labs every three months during the first year, then every six months thereafter. At cash-pay rates, annual monitoring runs approximately $350 to $800 in Hawaii. Quest Diagnostics and Labcorp both operate draw sites on Oahu and Maui. Neighbor island patients may need to use local hospital labs or travel to a draw site.

Some telehealth platforms bundle lab monitoring into their subscription fees, which can reduce total out-of-pocket costs. A 2024 analysis in JAMA Network Open found that patients using bundled telehealth-plus-lab services spent 22% less on total medication management costs compared to those coordinating care independently [20].

Generic vs. Brand vs. Compounded: A Direct Comparison

Three formulations of sirolimus are available to Hawaii patients, each with distinct pricing and practical considerations.

Generic sirolimus tablets (manufactured by Biocon, Zydus, and others) cost $65 to $110 per month at Hawaii retail pharmacies. They require no special handling and are stocked at most chain pharmacies. The standard tablet strengths are 0.5 mg, 1 mg, and 2 mg. Weekly longevity dosing of 5 mg typically means taking five 1 mg tablets on a single day each week.

Brand Rapamune (Pfizer) costs roughly $600 per month at list price but is rarely purchased at that price. With manufacturer coupons or insurance, copays drop to $40 to $75. Rapamune is available as tablets (0.5 mg, 1 mg, 2 mg) and an oral solution (1 mg/mL). The oral solution offers flexible dosing but requires refrigeration and has a 30-day shelf life once opened [3].

Compounded sirolimus capsules from 503A pharmacies cost $95 to $140 per month. The primary advantage is dose customization. A compounding pharmacy can prepare a single 5 mg or 6 mg capsule for weekly dosing, eliminating the need to count and swallow multiple tablets. Compounded formulations are not FDA-approved, which means they bypass the standard bioequivalence testing required of generic manufacturers [11].

For most Hawaii patients paying cash for off-label use, generic sirolimus tablets offer the best value. Compounded capsules make sense for patients who need non-standard doses or have difficulty swallowing multiple tablets.

The 2024 PEARL trial used commercially available generic sirolimus tablets, which provides some reassurance that generic formulations perform adequately in the longevity context [10].